3D Bioprinting Market to Witness Robust Growth in Coming Years

by Pramod Kumar Digital Marketing Professional

The market is registering growth due to the high demand for tissues and organs for transplantation, technological advancements and innovations, and rising compliance for drug discovery processes. 3D bioprinting is an additive manufacturing technology and refers to the process of creating 3D structures by making use of live cells. The process utilizes 3D printing technologies for creating live tissue or cell structures.

In terms of technology, the 3Dbioprinting market is categorized into pneumatic extrusion, laser-based, syringe-based, inkjet-based, and others. Among these, the syringe-based category dominated the market during the historical period (2012–2015) and is further predicted to account for the largest share of the market during the forecast period, contributing a share of over 35.0% in 2022. The pneumatic extrusion category is expected to grow at the fastest pace during the forecast period due to the advantageous features of this technology, as compared to the other technologies.

Receive Sample Copy of this Report:

When application is taken into consideration, the 3Dbioprinting market is divided into pharmaceutical, tissue & organ regeneration, 3D cell culture, and others. Out of these, the tissue & organ regeneration application dominated the market during the historical period and is further predicted to account for the largest revenue share of more than 55.0% in 2022. The 3D cell culture category is expected to witness the fastest growth during the forecast period. This is because extensive research is being carried out in the field of stem cell around the world.

Make an Enquiry before Purchase:

The surging requirement for organs and tissues for transplantation is another major factor driving the 3D bioprinting market. There is a huge gap between the demand and supply of tissues and organs around the world. Several organs such as lung, heart, intestine, kidney, pancreas, and liver are required for patients who have non-functioning organs. The organ donation rates are low while the demand for new tissues and organs is surging. 3D bioprinting is capable of developing organs and tissues, which is why the research & development activities in this domain are increasing. 

Hence, the market is expanding due to the growing compliance for drug delivery processes and increasing demand for tissues and organs for transplantation. 

Sponsor Ads

About Pramod Kumar Advanced   Digital Marketing Professional

80 connections, 2 recommendations, 223 honor points.
Joined APSense since, July 17th, 2017, From Ave, United States.

Created on Apr 16th 2021 05:28. Viewed 74 times.


No comment, be the first to comment.
Please sign in before you comment.